MYCOF - Mydecine Innovations Group GAAP EPS of -$1.34
2023-04-03 03:50:37 ET
- Mydecine Innovations Group press release ( OTCPK:MYCOF ): FY GAAP EPS of -$1.34.
- The company had $11.03K in cash and cash equivalents as of December 31, 2022; the company received $1.8M subsequently in early January 2023 from the sale of investments.
For further details see:
Mydecine Innovations Group GAAP EPS of -$1.34